Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi aventis france, france - vigabatrin - film-coated tablet - 500 mg

Malta - English - Medicines Authority

health house pharma ltd t/as p&d pharmaceuticals ltd 38 woolmer way, bordon, hampshire, gu35 9q, united kingdom - vigabatrin - granules for oral solution - vigabatrin 500 mg - antiepileptics

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

100's (10's blister x 10) -

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c france - 100's (10's blister x 10) - tablet - 500mg / tablet - central nervous system-antiepileptics

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة ألفه للأدوية - ulfa pharma co. - vigabatrin 500 mg - 500 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis - vigabatrin - film-coated tablet - 500 mg

Namibia - English - Namibia Medicines Regulatory Council

aventis pharma (pty) limited - vigabatrin tablets 500 mg - tablets - vigabatrin tablets 500 mg

European Union - English - EMA (European Medicines Agency)

orphelia pharma sas - vigabatrin - spasms, infantile; epilepsies, partial - antiepileptics, - kigabeq is indicated in infants and children from 1 month to less than 7 years of age for:treatment in monotherapy of infantile spasms (west's syndrome).treatment in combination with other antiepileptic medicinal products for patients with resistant partial epilepsy (focal onset seizures) with or without secondary generalisation, that is where all other appropriate medicinal product combinations have proved inadequate or have not been tolerated.